Literature DB >> 14596503

Costs of radiotherapy.

Anders Norlund1.   

Abstract

A systematic assessment of radiotherapy for cancer was conducted by The Swedish Council on Technology Assessment in Health Care (SBU) in 2001. The assessment included an overview of the capacity for radiotherapy in terms of infrastructure of cancer care and an estimation of the costs of radiotherapy in Sweden. A postal questionnaire distributed to all 16 centres of radiotherapy in Sweden showed the following results: In 2000 there were 57 accelerators with complementary equipment in operation, 24 of which had been installed 10 or more years ago earlier. The total cost of external radiation therapy was estimated at SEK 427 million in the year 2000, or approximately 5% of the estimated total cost of oncology care in Sweden. The total cost of brachytherapy was estimated at SEK 43 million or about one-tenth of that of external radiotherapy. The total cost of external radiotherapy has increased since the last inquiry (1991) by about 16% more than the general inflation in Sweden, but at the same time the volume of fractions has increased by about 37%. Thus, an increase in the efficiency of external radiotherapy, calculated per fraction, was achieved in the 1990s. At the department level, there was a clear correlation between cost of salaries and output of fractions of external radiotherapy, thus indicating the adaptation of manpower to the volume of patients. There was an even higher correlation between the number of accelerators and the volume of fractions of radiotherapy, which suggests the occurrence of certain economies of scale in Swedish external radiotherapy.

Entities:  

Mesh:

Year:  2003        PMID: 14596503     DOI: 10.1080/02841860310011140

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  17 in total

1.  Randomized controlled trials in health technology assessment: overkill or overdue?

Authors:  Søren M Bentzen
Journal:  Radiother Oncol       Date:  2008-01-30       Impact factor: 6.280

Review 2.  Evolution of advanced technologies in prostate cancer radiotherapy.

Authors:  Nicholas G Zaorsky; Amy S Harrison; Edouard J Trabulsi; Leonard G Gomella; Timothy N Showalter; Mark D Hurwitz; Adam P Dicker; Robert B Den
Journal:  Nat Rev Urol       Date:  2013-09-10       Impact factor: 14.432

Review 3.  The evolution of brachytherapy for prostate cancer.

Authors:  Nicholas G Zaorsky; Brian J Davis; Paul L Nguyen; Timothy N Showalter; Peter J Hoskin; Yasuo Yoshioka; Gerard C Morton; Eric M Horwitz
Journal:  Nat Rev Urol       Date:  2017-06-30       Impact factor: 14.432

Review 4.  Demand for radiotherapy in Spain.

Authors:  A Rodríguez; J M Borrás; J López-Torrecilla; M Algara; A Palacios-Eito; A Gómez-Caamaño; L Olay; P C Lara
Journal:  Clin Transl Oncol       Date:  2016-08-04       Impact factor: 3.405

5.  Evaluation of time, attendance of medical staff, and resources during radiotherapy for breast cancer patients. The DEGRO-QUIRO trial.

Authors:  E Blank; N Willich; R Fietkau; W Popp; J Schaller-Steiner; H Sack; F Wenz
Journal:  Strahlenther Onkol       Date:  2012-01-14       Impact factor: 3.621

6.  Personal perspectives on the evolution of radiation therapy and future outlook for SRS.

Authors:  Ian Paddick
Journal:  J Radiosurg SBRT       Date:  2018

7.  Evaluation of time, attendance of medical staff, and resources during radiotherapy for head and neck cancer patients: the DEGRO-QUIRO trial.

Authors:  Wilfried Budach; Edwin Bölke; Rainer Fietkau; Andre Buchali; Thomas G Wendt; Wolfgang Popp; Christiane Matuschek; Horst Sack
Journal:  Strahlenther Onkol       Date:  2011-07-22       Impact factor: 3.621

Review 8.  Systematic review of hypofractionated radiation therapy for prostate cancer.

Authors:  Nicholas G Zaorsky; Nitin Ohri; Timothy N Showalter; Adam P Dicker; Robert B Den
Journal:  Cancer Treat Rev       Date:  2013-03-01       Impact factor: 12.111

9.  Protection of quality and innovation in radiation oncology: the prospective multicenter trial the German Society of Radiation Oncology (DEGRO-QUIRO study). Evaluation of time, attendance of medical staff, and resources during radiotherapy with IMRT.

Authors:  H Vorwerk; K Zink; R Schiller; V Budach; D Böhmer; S Kampfer; W Popp; H Sack; R Engenhart-Cabillic
Journal:  Strahlenther Onkol       Date:  2014-03-05       Impact factor: 3.621

10.  Evaluating the attendance of medical staff and room occupancy during palliative radiotherapy.

Authors:  Irenäus A Adamietz; Oliver Micke; Wolfgang Popp; Horst Sack
Journal:  Strahlenther Onkol       Date:  2014-05-13       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.